1. Home
  2. CCEL vs NMTC Comparison

CCEL vs NMTC Comparison

Compare CCEL & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.37

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$0.69

Market Cap

34.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCEL
NMTC
Founded
1989
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
34.3M
IPO Year
2022
2010

Fundamental Metrics

Financial Performance
Metric
CCEL
NMTC
Price
$3.37
$0.69
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
N/A
$2.23
AVG Volume (30 Days)
12.5K
210.3K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
4.45%
N/A
EPS Growth
104.39
80.43
EPS
0.17
N/A
Revenue
$25,384,279.00
$9,097,692.00
Revenue This Year
$0.30
N/A
Revenue Next Year
N/A
$32.08
P/E Ratio
$19.82
N/A
Revenue Growth
9.76
163.47
52 Week Low
$3.10
$0.40
52 Week High
$7.91
$1.15

Technical Indicators

Market Signals
Indicator
CCEL
NMTC
Relative Strength Index (RSI) 49.35 40.54
Support Level $3.33 $0.57
Resistance Level $3.57 $0.72
Average True Range (ATR) 0.14 0.06
MACD 0.01 -0.01
Stochastic Oscillator 68.87 15.10

Price Performance

Historical Comparison
CCEL
NMTC

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: